Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

989
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
989
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.3K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.3K
Drug Classes and Categories01:25

Drug Classes and Categories

3.4K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.4K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

352
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
352
Drug Dependence01:17

Drug Dependence

1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal hypertension screening frequency in adults: a systematic review.

BMC primary care·2026
Same author

Retention and Other Efficacy Outcomes With Long-Acting Injectable Buprenorphine (Buvidal<sup>®</sup>) in France: A National Retrospective Cross-Sectional Study (OPALE 2).

Substance use & addiction journal·2026
Same author

Efficacy and safety of transcranial direct current stimulation in alcohol use disorder: A randomized controlled triple-blind trial.

Addiction (Abingdon, England)·2026
Same author

Co-occurring psychiatric disorders are key determinants of disability in alcohol use disorder: a cross-sectional analysis in 157 recently detoxified patients.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Same author

The hidden burden of narcolepsy type 1: Discordance in psychobehavioral symptoms between patient self-reports and reports from close family members and friends.

Sleep medicine·2026
Same author

Structural brain effects of alcohol use patterns in alcohol use disorder: A systematic review and Meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026

Related Experiment Video

Updated: Apr 7, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

[Cannabis use: what to do in general practice?].

Victoire Benard1, Benjamin Rolland1, Nassir Messaadi2

  • 1CHU de Lille, université Lille Nord de France, service d'addictologie, 59000 Lille, France.

Presse Medicale (Paris, France : 1983)
|July 7, 2015
PubMed
Summary

Cannabis use is increasingly common in young adults, posing public health challenges. General practitioners can identify risky use and cannabis use disorder (CUD) for timely intervention and care coordination.

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.1K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

819

Related Experiment Videos

Last Updated: Apr 7, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.1K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

819

Area of Science:

  • Public Health
  • Addiction Medicine
  • General Practice

Context:

  • Cannabis use is prevalent among young adults (15-34 years), surpassing alcohol and tobacco use.
  • Identifying and assessing cannabis use is a critical public health issue in general practice.
  • Medical and psychiatric complications associated with cannabis use require careful management.

Purpose:

  • To outline a two-step screening process for cannabis use in general practice: identifying risky use and diagnosing cannabis use disorder (CUD).
  • To emphasize the role of general practitioners (GPs) in managing cannabis use, including brief interventions and referral decisions.
  • To highlight the utility of DSM-5 criteria for assessing CUD severity and associated consequences.

Summary:

  • The screening process involves identifying risky cannabis use, which warrants a brief intervention by the GP.
  • For diagnosed cannabis use disorder (CUD), DSM-5 criteria aid in assessing severity and consequences.
  • GPs play a crucial role in coordinating patient care, managing complications, and referring to specialized units when necessary.

Impact:

  • Empowers general practitioners with tools to effectively screen for and manage cannabis use and CUD.
  • Facilitates early intervention, potentially mitigating the medical and social consequences of cannabis use.
  • Improves the integration of addiction care within primary healthcare settings for better patient outcomes.